CNBT
RMD icon

Canandaigua National Bank & Trust’s ResMed RMD Stock Holding History

Canandaigua National Bank & Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,044
Closed -$239K – 333
2024
Q4 		$239K Sell
1,044
-84
-7% -$20.2K 0.02% 292
2024
Q3 		$275K Sell
1,128
-244
-18% -$54.5K 0.03% 277
2024
Q2 		$263K Sell
1,372
-3
-0.2% -$609 0.03% 264
2024
Q1 		$272K Sell
1,375
-27
-2% -$4.95K 0.04% 232
2023
Q4 		$241K Buy
+1,402
New +$215K 0.04% 233
2023
Q3 		– Sell
-1,144
Closed -$250K – 268
2023
Q2 		$250K Sell
1,144
-58
-5% -$12.9K 0.04% 229
2023
Q1 		$263K Buy
+1,202
New +$261K 0.04% 221
2020
Q1 		$288K Sell
1,957
-422
-18% -$67.2K 0.06% 187
2019
Q4 		$369K Sell
2,379
-100
-4% -$14.4K 0.06% 192
2019
Q3 		$335K Sell
2,479
-79
-3% -$10.3K 0.06% 204
2019
Q2 		$312K Sell
2,558
-127
-5% -$14.1K 0.06% 212
2019
Q1 		$279K Sell
2,685
-277
-9% -$28.6K 0.05% 226
2018
Q4 		$337K Sell
2,962
-596
-17% -$63.9K 0.07% 187
2018
Q3 		$410K Sell
3,558
-283
-7% -$31K 0.07% 189
2018
Q2 		$398K Sell
3,841
-39
-1% -$3.95K 0.08% 192
2018
Q1 		$382K Buy
+3,880
New +$367K 0.05% 248

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Canandaigua National Bank & Trust's RMD Position: Q1 2025 in Review

Canandaigua National Bank & Trust sold out of ResMed (RMD) in Q1 2025, closing a stake of 1,044 shares — an estimated $239K sold.

Canandaigua National Bank & Trust first reported a position in RMD in Q1 2018 and held it in 16 quarters. The position peaked at $410K in Q3 2018. 886 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Canandaigua National Bank & Trust reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Canandaigua National Bank & Trust sold 1,044 ResMed shares in Q1 2025, an estimated $239K.
  • Canandaigua National Bank & Trust first reported a position in ResMed in Q1 2018 and held it in 16 quarters.
  • Canandaigua National Bank & Trust's ResMed position peaked at $410K in Q3 2018.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Canandaigua National Bank & Trust's 13F filing for Q1 2025, filed 25 Apr 2025.